A Study on Efficacy and Safety of Topiramate in the Treatment of Patients With Obesity
Status:
Completed
Trial end date:
2001-07-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to compare the safety and effectiveness of topiramate (64mg,
96mg, 192mg, and 384mg daily) with placebo in the treatment of obesity.
Phase:
Phase 2
Details
Lead Sponsor:
Johnson & Johnson Pharmaceutical Research & Development, L.L.C.